Home Search

dfco - search results

If you're not happy with the results, please do another search

Stem Cell Play Organicell (BPSR) Screams Higher.

Stock Levitates After Series of Positive Press Releases on Zofrin. Added to the Watch List in April a little more than a year ago after...
Tiki Hut Fund

Seven of the World’s Top Performing Stocks, Every Morning

THE TIKI HUT FUND | MONDAY'S BIGGEST MOVERS Schizophrenic Trading in Reviva Pharmaceuticals (RVPH) up 101% Shares of Reviva Pharma soared 76.6% in trading...
Tiki Hut Fund

Seven of the World’s Top Performing Stocks, Every Morning

THE TIKI HUT FUND | BIGGEST MOVERS | 6 MONTHS Ocugen Screaming Higher On CoronaVirus Vaccine News A post on LinkedIn by Ocugen CEO Shankar Musunuri...
Tiki hut fund

Seven of the World’s Top Performing Stocks, Every Morning

THE TIKI HUT FUND | TODAY'S BIGGEST MOVERS Welbilt Inc. (WBT) $22.58 | Screams Up 44.47% Welbilt shareholders woke up to a nice surprise yesterday. After...
Mitesco, Biotech Stock Review, roland rick perry

Short Squeeze Mania.

Citius Pharma (CTXR) Locked and Loaded. Truly Locked and Loaded. Latest $20 Million Round is Biggest News We've Seen From Citius Pharma (CTXR) Since We've...

Make Hay While the Sun Shines. Up 6,400%.

Celcius (CELH) We're Up 6,400%. Alkaline Water (WTER) We're Up 12%.Dicerna (DRNA) We're Up 700%. Ready to Breakout?BioSig (BSGM) We Have Another Double. BioSig...
Internet Stock Review

Newsletter: Institutional Analyst. And Yes, We Have Another Double.

1. Dalrada (DFCO) $0.19. And Yes, We Have Another Double!2. Dyadic (DYAI) $6.40. We're Up 392%, Video Presentation.3. BioSig (BSGM) $4.70. We're Up 60%,...
Hapbee, Biotech Stock Review

Telehealth App Hapbee (HAPB) Goes Public and More.

1. Hapbee (HAPB) $0.30, Going Public.2. Saying Goodbye to Immunomedics (IMMU) $86.3. Adding Biosig (BSGM) $2.95, to Watch List.4. Dalrada (DFCO) $0.11, Cancer Screening Test...
Dalarada Health, Biotech Stock Review

Dalrada Cervical Cancer Testing Kit Study.

KEY TAKEAWAYS Dalrada Corp (DFCO) LIVE QUOTE This was admittedly a small test, with only 100 patients. But keep in mind in the first place, this isn't...
biotech stock review

Dalrada’s ‘VIA’ Test Screening Kit Goes Head to Head with ‘Pap’ Smear Test Screening.

DALRADA aims to introduce its VIA Test kit to females in India - of which there is 497 million. https://youtu.be/fXwvdN4XnKU In 2012, the U.S. Preventive...

Latest article

Adding BCM Resources Corporation (B.V) $0.27, Up 42%, to Watch List.

'Elephant Hunter' Dr. Sergei Diakov is Expanding Drill Footprint, to Outline a Potentially Massive Copper-Gold System Beneath the Surface. Led by legendary geologist Dr. Sergei...

New Report on Sekur Private Data (SWISF). Palantir’s Open Secure AI.

Palantir CEO Alex Karp discusses open-weight artificial intelligence models, how he believes the technology should be regulated and why the U.S. should avoid Europe’s...

Replimune (REPL) Jumps 100%.

A Nifty $415 Million Gain (in an hour) for Shareholders. Not out of the woods yet.. Short and to the point: We listened to whole meeting...